Cotreatment with panobinostat and JAK2 inhibitor TG101209 attenuates JAK2V617F levels and signaling and exerts synergistic cytotoxic effects against human myeloproliferative neoplastic cells.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples